Our November issue is live! Including research on hip #osteoarthritis, #JIA, #LowBackPain, and #PsoriaticArthritis, plus much more! https://t.co/nv6Ef1MA30 Cover by Sara Gironi Carnevale

NEW—The @NobelPrize celebrates tolerance News story by Heather Van Epps https://t.co/ndqFyHZquR

"Better Politics Eventually" • K-Jobs Education • Pro-Guns & Borders • Pro-Obamacare • Pro-Faith/Family • Pro-Pot • Pro-Sustainability • Pro-Tariff • Pro-Diversity • Instant Run-off Voting

NEW Profile—Sharon Dowell: specialised treatment for the many https://t.co/ZeqRtmgkdP

Out today! In the RAMUS study we tested the effects of tofacitinib on muscle in people with #rheumatoidarthritis 🦵After 6 months, thigh volume increased by 5% 🧬 Muscle genes changed after TOFA and showed opposite pattern to age-related sarcopenia

Attending #ACR25? Sophie Woolven, Deputy Editor, invites you to reach out with enquiries. Explore our scope, reach & impact, commitment to publishing excellence, & more: https://t.co/9k3ePHlTSg

ICYMI

NEW REVIEW—@DrRyanHum and colleagues discuss synovial immunopathology in psoriatic arthritis: cellular and molecular insights https://t.co/fhLFfzurHV

Can AI be used to classify the focus score in Sjögren's disease? Linked Comment by Tamandeep K Bharaj & Kathrine Skarstein https://t.co/oAechhqfxy

NEW RESEARCH—Machine learning to classify the focus score and Sjögren's disease using digitalised salivary gland biopsies: a retrospective cohort study https://t.co/FUhwTZMwMJ

NEW podcast episode🎧 Deputy Editor, Sophie Woolven, talks to @ScottUhlrich about personalised gait retraining for knee #osteoarthritis Apple: https://t.co/TaiA8cmquf Spotify: https://t.co/IE38WKgkav Full Article: https://t.co/Up88ZaSnRW

Our October issue is live! Including research on #vaccination in #rheumatoidarthritis and #hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! https://t.co/XGoKvOAJDo Cover by Sara Gironi Carnevale

NEW RESEARCH—The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021 https://t.co/bfR5pb6So2 #GBDStudy @IHME_UW

NEW—Unscientific vaccine policy endangers vulnerable patients Read our latest editorial https://t.co/Z1TtxqK0WR

Modelling allopurinol-induced severe adverse cutaneous reactions Linked Comment by @Drbeckyg & Lisa K Stamp https://t.co/BhtTZjOjOZ

NEW RESEARCH—Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data https://t.co/NQAqGzM02I

NEW COMMENT—Targeting B-cell activation to tackle both patient-reported and systemic disease outcomes in Sjögren's disease https://t.co/ksHKDfYMSg

Biomarkers for juvenile idiopathic arthritis treatment response—have we identified them? Linked Comment by Stephanie KA Wong & @MarinkaTwilt https://t.co/A8LCNOAnM9

NEW RESEARCH—Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial https://t.co/aA1zZVL91s @cly_chew #JIA

@ArvindKaul20 @AustinKulasekar @sinisauksav Mapping the infectious burden in VEXAS syndrome: a systematic review and rationale for prevention Valentine Ribier and colleagues characterise the infectious burden of VEXAS syndrome and propose preventive strategies https://t.co/6IKJ8tbovW

VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms Arvind Kaul and colleagues explore the links between VEXAS syndrome and rheumatic diseases, offering guidance on current management strategies https://t.co/lce7SPYaWU